Biotechnology and renewable chemical company Amyris, Inc. (NASDAQ: AMRS) recently revealed that the company has entered into a joint venture and licensing agreement with Brazilian beef exporting company Minerva Foods’ subsidiary, MF 92 VENTURES LLC. The venture is likely to receive its first license revenue before the end of 2021, and is expected to deliver its first commercial production of its initial targets in 2022. Following the news, shares of the company gained 2.4% to close at $5.59 in Thursday’s trading session. Strategic Impact Amyris and Minerva will be looking to develop and produce new target molecules and bring them to the market commercially.
https://www.tipranks.com/news/amyris-minerva-enters-into-a-joint-venture-agreement?utm_source=advfn.com&utm_medium=referral